Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19685760	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 288.6"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 285.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		32000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Cytosol"		"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	75.2	203.0	23.1	15.2	32.5	9.3	34.9	24.8	27.7	49.4	71.7	49.6	68.1	29.4	41.7	131.3	38.3	70.5	44.6	29.0	27.9	173.0	288.6	59.1	14.9	23.3	26.3	32.3	52.3	40.6	21.9	11.8	23.5	75.0	36.5	40.8	61.7	41.5	53.0	207.6	71.8	30.2	25.1	19.4	81.5	26.9	24.8	23.0	75.1	100.9	36.4	24.2	40.5	33.6	27.7	147.0	29.2	58.5	88.7	89.4	19.1	12.3	29.9	24.4	27.6	63.2	52.5	12.3	35.9	50.5	29.3	99.0	59.8	125.2	19.9	36.2	42.5	5.3	120.9	142.8	12.2	30.6	5.4	42.9	137.6	22.9	12.2	49.7	49.2	25.5	2.2	0.6	37.3	45.3	0.7	25.2	32.3	285.4	78.5	38.6	64.1	25.3	17.5	132.3	46.3	30.4	98.9	38.4	35.3	152.2	78.1	35.0	46.7	10.1	28.7	68.8	45.6	11.3	28.6	15.5	47.4	0.3	48.3	0.8	21.1	17.5	6.3	18.3	9.9	5.2	6.0	6.1	20.7	4.9	6.8	6.3	2.2	15.0	20.6	1.3	11.3	11.0	23.1	32.5	24.8	27.7	29.0	27.9	23.3	26.3	23.5	25.1	24.8	33.6	22.1	176.3	86.5	14.7	13.3	57.1	143.9	85.1	287.4	15.3	13.6	24.0	54.1	105.8	86.5	33.1	12.5	12.5	8.2	48.9	43.0	97.5	79.6	47.5	13.4	19.5	16.2	8.2	30.5	52.0	4.6	39.9	87.7	36.9	29.7	34.6	13.6	116.7	24.6	6.7	20.1	27.7	26.4	21.7	15.1	19.5	55.9	23.5	7.2	13.1	25.7	105.9	8.2	19.6	29.1	43.9	28.7	80.5	28.6	104.2	90.6	119.2	59.2	21.4	13.1	70.1	22.1	15.5	24.0	232.6	90.2	1.4	13.2	29.1	46.0	51.4
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 889.6;liver: 2472.0"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	309.5	109.6	38.4	31.2	39.7	25.3	253.5	42.2	45.2	86.0	37.6	146.5	438.2	44.9	176.2	78.1	81.9	301.2	84.8	37.5	38.8	889.6	2472.0	356.6	43.7	43.1	39.7	223.9	461.3	236.0	58.5	81.8	41.9	95.9	103.4	10.3	59.1	122.8	41.4	118.4	381.7	46.7	40.8	75.6	194.8	57.9	40.0	51.6	42.5	42.1	35.2	155.5	68.3	43.5	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	38.4	39.7	42.2	45.2	37.5	38.8	43.1	39.7	41.9	40.8	40.0	43.5	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367646	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"adrenal gland: 1009.9"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 345.1;Peritubular cells: 173.8;Syncytiotrophoblasts: 1452.0;Theca cells: 637.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 10.2"	"Group enriched"	"Detected in some"	5	"BEWO: 55.2;HEL: 46.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1.8;hippocampal formation: 1.1;hypothalamus: 1.3;midbrain: 4.5;pons: 1.1"	HPA016436	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA016436: AB_1847423"	"unprognostic (8.89e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.31e-2)"	"unprognostic (9.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (9.66e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.95e-2)"	2.0	1009.9	2.0	0.6	2.1	0.1	1.9	2.3	2.0	2.0	3.5	0.8	0.3	1.6	0.8	6.3	2.4	0.4	1.4	2.0	2.1	0.6	3.6	0.6	0.1	2.8	2.5	38.9	0.3	0.0	2.8	25.2	2.8	1.2	0.2	0.7	1.2	0.5	2.5	0.6	0.8	0.9	2.6	4.9	0.9	23.0	1.9	0.3	0.3	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.0	0.2	0.0	0.4	55.2	0.1	0.0	0.4	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	46.8	1.2	0.5	0.2	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	11.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	2.1	2.3	2.0	2.0	2.1	2.8	2.5	2.8	2.6	1.9	1.9	0.1	0.0	0.0	6.2	0.0	0.3	0.0	0.0	34.1	0.1	0.6	0.9	1.2	2.8	0.0	0.0	0.0	144.6	0.0	0.0	1.9	0.0	1.6	0.2	4.9	0.8	0.0	0.0	0.2	0.0	345.1	10.0	0.0	0.2	0.0	41.3	0.0	3.6	22.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	48.7	0.4	0.0	1.0	0.6	6.2	0.0	0.0	0.2	0.5	0.0	173.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.2	4.6	2.8	8.7	0.0	1452.0	0.0	637.4	0.0	0.0
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849627-54887195	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1129.5;liver: 623.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 298.1;Alveolar cells type 2: 682.3;Hepatocytes: 1091.4;Theca cells: 442.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1031.9"	"Low region specificity"	"Detected in all"							"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	58.3	1129.5	35.7	19.8	58.5	1.6	104.8	125.3	73.0	54.9	30.4	55.6	62.2	13.1	1.6	296.1	60.4	42.2	18.0	55.9	63.9	48.6	623.5	215.9	9.4	216.2	91.3	28.5	30.5	157.9	17.0	21.6	158.9	128.6	40.5	15.8	136.2	8.3	197.7	247.6	29.6	12.6	129.3	134.1	98.9	74.2	87.9	10.1	15.4	11.1	33.9	13.5	103.9	280.7	342.1	58.5	210.6	257.1	1031.9	219.0	50.5	94.8	160.3	130.7	268.6	341.6	210.2	55.3	191.5	82.4	427.4	319.2	250.5	501.3	118.3	8.3	159.6	303.3	131.8	421.7	168.9	126.7	68.2	161.0	429.0	397.6	74.7	66.7	67.2	124.5	224.7	0.2	50.2	143.5	25.8	111.4	592.0	90.7	164.2	0.3	54.2	166.3	735.3	257.1	144.5	53.2	185.0	337.5	123.1	221.6	441.5	143.3	62.2	45.3	130.0	66.1	183.9	22.7	55.0	91.2	32.8	215.3	60.4	5.1	1.5	0.7	6.0	1.8	0.3	3.7	2.5	2.6	5.2	1.3	2.2	2.9	0.0	2.7	0.7	3.0	0.4	4.4	35.7	58.5	125.3	73.0	55.9	63.9	216.2	91.3	158.9	129.3	87.9	280.7	6.2	298.1	682.3	12.4	13.3	31.5	17.3	150.6	79.1	9.7	87.9	33.1	15.3	145.8	205.2	68.0	0.0	35.2	6.4	133.3	3.9	55.3	22.9	14.5	5.8	13.5	24.0	71.6	14.5	76.5	34.4	17.5	38.7	44.7	32.2	26.4	111.0	1091.4	28.0	5.0	8.7	39.2	69.2	68.9	8.2	77.2	14.0	9.4	14.2	1.9	6.8	3.6	2.1	5.5	62.6	48.6	27.7	7.9	1.8	52.4	22.6	14.4	136.3	6.4	0.0	1.5	23.2	5.4	14.7	145.4	80.4	30.6	10.6	442.4	35.2	45.2
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627464	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.6"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.8;U-266/70: 44.0;U-698: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	3.3	3.1	0.8	4.0	1.1	2.6	1.6	1.6	1.4	2.3	1.6	4.7	6.2	1.9	1.0	1.6	1.3	1.4	1.5	0.8	1.5	2.0	1.9	1.8	3.2	1.0	1.2	1.9	19.6	3.4	1.1	3.2	0.9	4.0	1.8	0.1	9.7	1.2	2.0	1.4	5.0	0.9	1.5	3.1	12.3	1.0	1.2	1.3	3.5	0.0	2.3	1.9	1.8	2.1	8.7	3.3	1.2	4.3	2.8	2.0	15.9	12.4	1.1	0.7	2.1	3.5	2.9	46.8	8.0	1.3	3.1	7.2	1.6	1.3	1.1	25.3	7.1	4.6	1.7	2.0	1.1	3.9	12.3	0.1	1.5	0.7	2.0	0.8	1.4	4.9	3.0	8.7	0.6	4.4	5.5	2.2	6.2	2.7	7.2	25.1	7.0	8.2	1.3	5.0	5.6	9.9	6.3	6.5	8.2	1.7	2.2	4.4	3.9	2.5	5.5	10.8	7.1	44.0	24.4	31.0	4.6	4.2	6.2	0.0	0.1	0.1	0.3	0.0	0.2	1.0	0.2	0.8	0.1	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.8	1.1	1.6	1.4	0.8	1.5	1.0	1.2	0.9	1.5	1.2	2.1	9.2	9.6	7.5	14.7	43.8	20.3	8.9	7.2	26.7	8.4	14.7	8.9	8.2	17.2	7.2	12.9	8.4	4.1	13.4	14.0	0.0	3.7	0.1	18.4	18.3	7.6	13.7	1.7	31.3	6.5	6.9	15.2	40.2	39.2	1.3	4.4	8.9	11.8	4.6	1.7	39.0	30.1	14.2	5.1	41.2	0.7	7.5	27.7	32.0	21.5	3.9	3.0	9.2	20.1	26.2	7.0	7.7	5.7	121.3	13.0	5.4	2.9	7.7	2.3	0.0	13.4	9.4	3.1	3.6	23.8	18.3	6.7	12.8	3.5	6.8	16.6
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365253-31376850	"Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 5666.1;skeletal muscle: 2202.5;tongue: 1442.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 629.8;Cardiomyocytes: 2495.2;Distal tubular cells: 452.0;Proximal tubular cells: 703.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"ASC TERT1: 215.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	3000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	31.4	63.5	33.7	2.1	39.2	1.6	95.4	42.3	51.5	40.4	14.8	16.3	0.8	93.9	6.4	9.5	37.2	3.7	5666.1	52.0	37.3	229.8	6.6	26.4	3.4	50.5	38.3	20.3	2.2	0.3	9.0	2.8	55.2	48.9	4.8	17.8	46.5	52.2	2202.5	16.3	7.5	44.2	31.4	28.8	60.3	15.3	36.1	2.3	6.8	1442.4	1.4	12.5	32.5	36.8	1.0	0.4	8.8	1.1	50.6	215.0	2.0	2.6	17.3	0.3	6.6	1.3	1.9	1.6	17.8	5.2	0.3	2.1	2.5	0.0	0.5	0.8	3.7	1.8	2.7	5.3	2.2	1.7	0.5	16.9	0.0	3.9	0.0	2.5	0.0	1.4	2.2	0.5	2.2	0.5	0.7	1.5	11.4	0.9	3.1	0.4	5.7	0.6	4.1	0.7	2.1	0.5	1.5	0.7	28.4	13.2	0.9	3.1	1.7	1.0	1.0	6.0	1.3	1.0	2.3	1.3	2.9	1.5	1.7	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.1	33.7	39.2	42.3	51.5	52.0	37.3	50.5	38.3	55.2	31.4	36.1	36.8	4.9	0.0	1.7	2.9	7.7	3.6	1.5	0.4	0.0	6.1	629.8	13.2	2495.2	2.8	1.3	27.6	2.1	3.8	2.1	0.4	452.0	0.4	2.5	0.4	0.5	25.6	0.0	0.0	16.1	0.4	1.4	67.2	1.1	3.1	1.3	43.8	2.2	0.1	114.7	8.4	14.6	0.1	0.0	27.8	10.3	5.4	6.8	19.1	8.8	3.7	0.0	2.6	0.0	3.5	8.9	0.3	12.3	7.9	0.1	6.8	0.1	703.6	1.5	10.2	0.0	14.9	40.7	2.9	0.2	0.2	3.0	1.6	5.1	97.9	0.3	36.5
FADS1	"D5D, FADS6, FADSD5, LLCDL1, TU12"	ENSG00000149485	"Fatty acid desaturase 1"	O60427	11	61799627-61829318	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 521.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042705	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA042705: AB_10795709"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (1.95e-9)"	"unprognostic (2.29e-2)"	"unprognostic (3.59e-2)"	"prognostic unfavorable (2.79e-4)"	"prognostic unfavorable (1.33e-4)"	26.2	67.7	43.1	19.8	39.2	9.7	13.6	38.4	40.7	19.6	70.7	9.5	5.5	21.3	6.6	5.2	17.4	14.5	22.6	39.3	58.5	9.7	52.8	20.3	9.8	57.9	62.1	27.5	10.0	27.2	21.3	21.1	52.2	19.6	4.9	35.1	6.4	15.8	17.5	15.5	6.7	20.5	46.4	8.0	9.4	11.9	68.7	8.1	6.0	7.8	9.2	12.7	10.2	56.0	66.3	170.1	159.1	41.1	313.2	521.2	46.4	42.0	204.5	69.9	118.9	53.3	143.2	2.3	43.4	60.5	177.2	84.7	130.8	114.1	51.7	12.2	18.4	107.9	191.2	98.9	169.1	23.4	10.4	238.1	38.3	154.7	74.7	73.8	64.1	104.7	59.9	118.6	70.1	18.6	78.6	23.6	94.2	5.5	63.0	85.4	162.5	231.2	81.5	29.0	80.7	89.6	106.7	1.7	90.0	58.4	38.6	98.6	62.1	71.8	70.8	74.2	50.6	112.9	111.3	55.4	42.6	108.9	61.4	7.5	33.2	6.2	12.1	40.4	2.6	2.5	4.0	4.9	28.0	8.7	2.3	5.4	2.6	6.9	17.4	23.6	2.9	15.7	43.1	39.2	38.4	40.7	39.3	58.5	57.9	62.1	52.2	46.4	68.7	56.0	10.3	6.4	77.9	28.7	3.2	2.7	2.5	48.5	1.2	78.9	2.6	3.7	30.4	8.6	25.3	12.9	27.1	9.5	12.4	0.9	0.0	15.2	8.7	4.9	30.7	16.6	9.7	46.3	9.4	33.4	50.0	34.9	6.1	7.8	37.9	65.3	9.3	74.5	37.2	69.0	14.7	0.6	16.2	21.7	21.0	16.4	29.8	27.6	32.0	12.2	32.0	70.5	6.2	13.6	27.4	7.6	0.0	21.4	2.1	6.4	0.1	1.1	8.0	91.9	0.0	40.3	31.9	6.5	17.5	2.3	1.4	9.3	5.5	75.2	1.4	1.6
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"		Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 409.3"	"Cell type enriched"	"Detected in some"	19	"Theca cells: 24080.8"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7"									HPA028615	Enhanced				"Secreted to blood"	NA	NA	566000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"			"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.5	1.6	1.2	4.8	1.3	1.8	0.5	2.3	1.5	0.1	1.3	0.5	1.5	0.3	0.8	0.6	0.8	0.4	0.2	1.4	1.5	0.5	0.4	0.9	2.9	1.2	1.3	29.6	0.2	0.0	0.2	0.3	1.4	0.6	0.0	0.1	0.6	0.0	0.2	0.3	1.7	0.0	1.2	5.2	0.8	409.3	1.5	0.5	0.3	0.4	1.2	0.4	0.3	1.3	0.2	0.6	0.1	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.1	0.1	1.4	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.5	0.0	0.2	0.0	0.0	1.2	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	1.0	0.2	1.1	0.0	1.1	2.6	0.9	0.0	0.1	0.1	0.3	5.2	4.7	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	2.1	0.1	0.1	1.3	0.0	0.4	0.2	0.0	0.7	0.4	0.7	0.0	0.9	0.9	0.1	1.1	0.7	1.0	2.2	0.5	0.1	0.1	0.8	0.5	1.2	1.3	2.3	1.5	1.4	1.5	1.2	1.3	1.4	1.2	1.5	1.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.1	6.8	0.0	0.1	3.4	0.0	0.0	0.3	0.0	0.4	42.3	0.0	0.0	0.0	0.9	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	257.1	1240.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	998.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.9	5.7	0.0	0.0	0.5	0.8	24080.8	0.0	0.0
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089462-11133820	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 112.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 397.4;Alveolar cells type 2: 468.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 46.0"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 46.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved					NA	NA		23000000	"Cluster 38: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.43e-4)"	43.6	112.1	6.4	27.3	7.5	27.4	15.6	8.6	13.0	27.5	22.0	20.0	23.6	21.6	3.8	50.1	21.6	36.9	19.3	8.4	10.8	15.2	60.4	54.8	4.8	24.3	14.4	37.7	50.7	10.1	6.9	16.6	20.0	20.2	12.2	2.3	19.1	4.6	3.9	25.5	18.3	28.6	9.9	10.5	36.5	8.4	11.7	4.0	7.7	4.0	5.1	22.6	25.8	14.5	113.6	52.2	61.1	29.9	80.5	152.7	21.0	23.5	89.8	41.3	88.6	52.9	105.3	37.2	94.1	46.1	135.6	88.3	31.1	185.6	19.9	27.5	6.1	18.1	34.5	47.1	120.2	19.2	100.9	192.5	67.5	139.6	30.2	28.5	45.8	29.5	38.9	213.8	31.9	41.4	25.3	25.9	66.4	56.0	67.5	17.1	44.9	48.2	103.1	89.5	14.8	15.4	21.1	45.7	3.8	45.2	19.0	44.6	50.8	36.1	26.3	23.2	44.7	26.8	24.4	23.3	42.8	43.7	83.6	46.0	2.9	0.1	5.4	2.6	1.3	0.6	2.2	1.7	1.6	0.5	2.3	2.2	0.8	2.5	0.8	0.5	1.6	3.2	6.4	7.5	8.6	13.0	8.4	10.8	24.3	14.4	20.0	9.9	11.7	14.5	106.3	397.4	468.6	16.3	8.1	143.4	176.8	182.2	85.4	11.4	144.0	108.7	35.9	92.9	205.7	14.7	6.2	18.4	24.7	273.7	1.9	57.9	1.2	95.3	61.7	75.8	61.9	6.6	10.7	89.0	32.1	42.9	195.2	278.6	75.9	32.9	22.9	149.2	14.9	1.7	8.1	157.2	77.3	16.5	26.5	1.6	19.6	47.4	56.9	7.5	2.7	6.8	8.2	7.5	19.4	86.7	209.7	7.2	30.7	142.7	32.5	0.6	99.1	6.6	6.6	133.4	48.4	4.1	2.8	155.3	197.2	48.2	32.8	214.3	110.7	184.2
MEDAG	"AWMS3, C13orf33, FLJ14834, MEDA-4"	ENSG00000102802	"Mesenteric estrogen dependent adipogenesis"	Q5VYS4	13	30906271-30925572	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 163.7"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 80.2;Fibroblasts: 122.4;Skeletal myocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 312.4;ASC TERT1: 87.4;U-2197: 175.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (8.69e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.41e-3)"	"unprognostic (7.52e-2)"	163.7	4.0	0.6	15.8	0.8	0.3	57.0	0.5	1.5	19.1	4.6	14.5	2.5	28.1	26.9	8.4	36.3	15.1	30.1	0.6	1.9	11.6	0.8	16.0	1.5	0.7	0.8	11.8	14.2	0.8	6.1	6.8	0.7	7.5	6.5	0.1	15.5	2.5	14.8	21.4	11.5	23.4	0.7	0.4	15.4	7.0	1.1	1.9	26.8	6.2	0.8	66.4	10.1	0.5	0.0	0.0	0.0	0.0	312.4	87.4	0.0	0.6	0.1	1.3	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.1	37.1	0.0	45.9	0.0	0.2	42.7	0.0	0.0	0.0	4.2	0.0	0.0	0.2	4.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	6.6	0.0	0.0	0.3	0.0	6.0	0.1	0.0	46.9	0.0	0.2	175.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.5	1.5	0.6	1.9	0.7	0.8	0.7	0.7	1.1	0.5	12.0	0.0	0.5	0.3	0.0	11.5	0.2	0.1	0.0	0.0	0.1	0.3	4.5	5.7	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.9	1.1	2.0	80.2	13.9	0.0	0.0	0.4	0.0	0.5	122.4	2.0	1.7	0.0	0.0	2.2	0.0	1.0	0.0	0.3	0.0	0.0	0.0	20.6	2.2	19.0	1.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	0.1	1.7	0.0	0.2	0.7	0.0	0.0	80.4	19.6	0.0	0.0	0.7	10.4	0.3	1.1	5.3	0.0	0.6
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 135.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	33.3	135.2	6.3	26.6	7.0	2.0	20.9	6.2	9.5	17.8	6.2	79.9	29.5	8.5	3.1	10.2	12.4	20.7	11.6	5.8	6.2	23.8	77.0	70.4	11.0	6.9	6.6	27.5	26.1	2.1	3.0	58.5	7.5	6.7	64.3	2.3	16.4	3.4	4.7	3.5	61.8	16.7	6.8	8.5	9.2	11.7	8.0	3.0	21.3	8.7	14.8	16.6	11.5	7.2	19.9	20.0	6.4	0.3	129.4	164.8	0.3	189.8	157.7	110.4	79.9	1.0	4.1	0.1	9.8	473.2	3.5	8.5	13.9	13.3	125.2	0.2	10.0	8.8	13.4	0.1	196.5	0.2	3.8	58.7	0.3	63.7	5.2	135.6	94.2	1.4	0.0	89.4	79.2	74.1	0.1	0.7	7.4	4.8	24.1	0.4	0.1	0.4	117.5	8.7	0.9	1.6	92.5	3.3	1.1	12.6	13.5	5.3	120.0	38.2	22.5	131.5	13.9	0.3	1.0	0.3	18.3	0.2	0.2	0.0	1.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	7.7	0.0	0.0	0.8	6.3	7.0	6.2	9.5	5.8	6.2	6.9	6.6	7.5	6.8	8.0	7.2	49.5	240.4	38.2	3.6	2.6	2.3	0.9	18.0	1.8	0.2	11.5	4.7	4.4	8.6	13.8	9.2	0.0	0.5	0.8	202.4	13.7	6.4	1.2	2.6	18.7	23.2	12.6	5.2	22.2	30.2	0.8	36.1	15.3	11.6	0.0	20.3	36.0	111.5	11.5	0.0	27.6	26.5	4.1	29.8	50.7	0.8	17.4	51.0	1.8	30.0	5.2	1.3	0.0	21.6	1.0	19.4	46.1	5.3	3.1	2.1	181.3	9.8	3.4	0.0	13.1	1.0	20.4	1.2	0.7	1.1	1.3	1.4	1.7	96.4	74.3	1.1
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 677.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 520.4;Theca cells: 907.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		1200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	108.0	171.3	97.9	37.5	102.5	25.1	106.0	83.8	115.5	135.4	96.3	98.2	109.3	154.5	273.3	57.0	149.0	56.9	38.6	102.3	127.0	235.4	677.4	62.1	27.6	97.2	109.3	93.3	40.2	113.9	59.1	44.9	126.1	127.6	87.3	80.5	71.4	200.4	15.7	53.2	131.9	85.2	106.1	41.4	77.1	46.5	112.8	33.4	89.0	27.0	29.3	77.3	65.0	116.9	165.6	102.4	196.3	227.7	414.2	196.9	127.1	243.0	281.0	126.1	155.7	124.5	196.6	47.3	259.5	253.8	147.3	128.3	216.5	102.1	168.8	50.8	248.7	53.7	88.5	141.0	69.0	88.4	27.5	204.7	56.5	153.8	79.2	93.5	82.6	55.7	57.2	28.8	150.3	176.5	66.9	64.7	515.8	179.4	170.3	78.5	123.1	68.5	168.7	123.9	182.9	81.7	178.1	291.7	98.9	188.2	67.4	56.2	64.2	87.6	127.7	312.6	233.6	29.9	59.2	51.0	238.8	138.6	170.6	21.0	20.1	20.4	8.7	19.9	11.8	5.8	12.0	12.9	17.0	5.5	12.0	10.1	9.1	8.8	18.4	12.0	13.4	50.2	97.9	102.5	83.8	115.5	102.3	127.0	97.2	109.3	126.1	106.1	112.8	116.9	109.1	125.0	91.4	16.0	19.0	94.1	131.3	67.4	81.4	199.1	110.8	95.1	17.1	120.1	76.7	73.5	68.8	88.2	25.8	170.5	68.4	93.0	4.2	119.7	264.2	81.9	57.7	37.6	36.5	73.0	138.6	153.1	50.4	122.4	40.5	197.0	66.4	520.4	51.8	65.6	58.5	85.0	81.4	35.0	51.2	9.0	172.1	111.1	103.2	15.0	26.5	109.8	18.6	108.6	91.3	68.9	144.7	181.7	22.6	118.8	375.5	295.1	105.4	92.4	105.2	99.2	111.1	68.2	77.2	69.3	87.7	62.1	32.1	907.9	137.6	127.9
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386984-67412167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	0.8	51.1	0.3	5.5	0.3	12.7	3.9	0.8	0.6	3.9	0.1	25.1	29.6	1.5	32.4	16.4	1.7	3.9	0.3	0.4	0.2	9.7	29.7	1.6	0.2	0.3	0.2	0.6	7.9	7.0	1.3	1.5	0.3	7.7	28.7	0.1	6.8	4.2	0.3	26.5	32.6	1.3	0.2	0.6	20.6	3.1	0.4	22.9	23.5	0.2	5.5	12.1	7.9	0.4	91.0	13.4	0.0	0.1	0.0	1.0	8.4	17.9	2.7	4.2	5.2	48.8	94.4	0.0	17.3	2.5	0.2	42.4	0.1	177.4	9.6	0.1	0.7	0.0	19.4	0.4	3.8	0.0	0.0	1.9	12.3	4.6	55.4	0.0	14.8	0.0	0.4	0.4	3.0	28.9	0.0	0.2	0.3	57.4	64.1	0.0	0.1	14.0	30.0	2.4	0.7	0.2	17.0	7.9	5.2	0.9	11.6	0.9	69.3	0.0	54.1	0.3	0.4	0.3	0.2	0.3	10.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.4	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.8	0.6	0.4	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.1	0.0	1.1	1.0	0.6	149.0	29.0	69.9	37.0	0.0	4.9	6.0	0.5	10.0	11.8	5.5	0.0	1.0	0.0	25.0	3.9	42.1	0.1	2.3	0.2	2.0	8.4	16.0	0.8	46.3	5.5	4.2	37.2	2.2	0.0	24.0	0.0	11.5	6.8	0.0	0.6	68.5	26.4	1.3	57.1	0.3	0.3	7.4	21.4	0.0	5.2	0.0	0.0	0.5	0.3	179.8	23.9	0.0	0.0	15.8	47.9	3.2	4.5	0.0	0.0	0.0	4.6	0.4	2.3	21.2	90.6	1.5	1.3	107.7	54.8	25.5
PRR13	"DKFZP564J157, FLJ23818"	ENSG00000205352	"Proline rich 13"	Q9NZ81	12	53441678-53446645	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 884.9;Distal tubular cells: 1365.6;Paneth cells: 858.1;Proximal enterocytes: 1642.7;Proximal tubular cells: 1097.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039396, HPA046219"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039396: AB_2676484, HPA046219: AB_10963936"	"unprognostic (1.09e-1)"	"prognostic favorable (9.08e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.55e-4)"	143.8	207.8	110.8	159.2	110.1	279.1	139.2	112.6	147.7	118.9	109.7	316.1	451.6	104.6	110.8	143.4	139.2	147.1	110.6	105.8	147.8	457.9	192.8	164.3	185.3	126.6	132.1	118.8	133.3	76.0	114.6	95.2	126.3	139.6	265.7	44.0	115.5	86.6	131.6	108.7	432.6	91.4	114.3	230.2	247.8	46.4	118.4	139.0	131.8	59.6	190.4	143.7	111.7	117.1	171.7	339.6	82.6	89.4	135.3	185.3	178.4	142.5	213.0	185.6	179.4	623.1	373.6	265.1	453.5	206.8	225.4	146.6	167.8	225.0	217.9	263.1	124.6	382.4	166.4	294.6	340.7	573.2	489.5	232.6	221.2	326.5	223.6	192.6	195.3	166.1	340.1	254.6	285.1	472.5	325.8	563.8	127.5	229.2	230.7	287.6	67.8	273.9	406.2	283.8	72.3	56.5	202.5	276.7	237.2	169.5	394.0	436.2	196.3	117.2	114.0	201.3	138.0	190.7	241.6	386.4	153.3	345.1	220.2	851.3	824.0	1620.1	511.1	941.9	503.0	888.2	563.7	545.8	649.3	855.6	520.6	557.7	2095.7	584.5	1014.6	539.0	824.8	1573.1	110.8	110.1	112.6	147.7	105.8	147.8	126.6	132.1	126.3	114.3	118.4	117.1	66.8	83.3	110.4	6.8	219.1	47.5	147.8	204.8	82.6	11.1	114.3	95.2	26.4	198.8	145.1	187.6	29.2	225.3	159.1	884.9	1365.6	228.0	12.6	182.7	67.1	80.3	169.8	99.2	6.3	253.9	337.7	76.6	263.0	127.4	186.7	53.4	78.1	152.8	355.2	18.5	7.1	346.9	193.3	345.0	174.4	8.7	58.1	266.8	108.5	9.4	384.7	85.3	297.6	4.5	12.9	332.3	858.1	45.9	120.9	174.7	1642.7	1097.6	215.9	20.9	78.9	33.6	67.1	29.7	22.8	107.1	56.0	291.0	212.7	88.4	340.0	193.1
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 1366.7;pancreas: 632.7"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 5988.6;Theca cells: 3228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SH-SY5Y: 835.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 64.4"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		41000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	23.7	377.1	64.6	18.4	65.2	1.3	49.5	64.9	72.7	53.8	251.4	30.3	32.3	180.2	64.2	35.4	390.2	182.9	60.1	65.5	67.8	46.9	140.8	26.8	18.6	83.1	69.0	1366.7	632.7	46.8	257.8	63.6	64.7	44.8	14.2	23.2	50.2	41.3	15.2	31.3	26.2	119.3	68.2	47.0	29.3	56.1	75.2	9.4	23.0	15.5	12.0	65.7	24.3	67.5	7.8	2.9	7.4	164.2	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.4	76.1	0.0	53.8	0.1	2.6	0.1	38.2	0.5	0.0	0.1	5.3	0.1	2.7	75.5	155.1	0.2	0.1	3.0	0.0	0.1	0.0	160.9	0.0	0.0	0.2	29.9	0.2	0.0	0.2	0.5	18.4	0.2	0.0	0.1	32.0	0.5	0.1	0.1	19.6	835.4	35.3	0.1	0.1	13.9	3.2	1.1	0.0	0.3	120.0	0.2	0.3	0.6	0.5	0.5	1.3	0.0	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	64.6	65.2	64.9	72.7	65.5	67.8	83.1	69.0	64.7	68.2	75.2	67.5	24.8	32.1	5.9	8.8	3.5	17.6	53.5	91.9	2.8	26.3	70.4	47.8	21.4	77.2	30.3	23.9	2.1	3.2	1.0	0.1	13.7	1013.0	4.8	199.6	961.4	103.8	43.1	13.5	0.5	1042.7	6.2	158.8	19.9	58.1	0.0	5988.6	343.7	6.9	16.5	3.3	0.3	2.3	42.7	10.6	3.4	16.2	27.1	25.1	8.8	5.6	13.5	159.9	0.0	4.0	16.0	563.0	0.0	4.5	2.9	56.6	2.6	4.7	10.3	7.2	26.3	220.9	534.7	11.6	4.9	6.2	34.9	3.8	10.2	3228.5	2.7	32.7
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
STAR	STARD1	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38142700-38150992	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Steroidogenesis, Transport"		"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"adrenal gland: 5073.8"	"Cell type enriched"	"Detected in some"	44	"Theca cells: 2243.4"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"K-562: 436.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023644, HPA027318, CAB032598"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"			"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	1.7	5073.8	2.3	3.1	1.6	2.1	0.4	1.6	3.3	1.0	0.7	0.5	0.2	0.5	0.6	2.1	6.3	0.2	0.9	1.5	4.5	0.4	1.2	0.5	0.9	3.8	3.3	497.1	0.9	0.0	2.2	0.5	4.1	0.5	0.1	0.6	1.8	0.3	0.4	5.0	0.6	0.4	1.4	1.0	0.7	88.2	3.0	3.0	0.4	0.0	1.9	0.5	3.2	1.5	0.1	0.0	0.8	0.2	0.3	3.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	88.9	0.8	5.3	1.3	3.8	0.1	12.4	0.3	0.1	0.1	0.8	0.0	0.3	436.1	0.2	0.0	0.0	0.4	43.7	9.6	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.2	0.0	0.2	0.0	0.1	43.0	1.5	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	9.3	0.2	2.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	2.3	1.6	1.6	3.3	1.5	4.5	3.8	3.3	4.1	1.4	3.0	1.5	0.0	0.0	0.0	0.7	0.1	9.4	0.7	0.8	4.0	1.1	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.9	10.7	0.6	0.0	0.0	1.4	0.0	0.0	25.7	0.0	0.3	0.0	1.4	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.7	10.2	50.1	0.2	3.6	0.0	0.0	0.6	0.0	0.5	0.3	0.1	0.0	4.1	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.2	3.0	4.8	0.8	1.7	11.2	0.1	0.1	2243.4	0.0	0.1
SYN1	MRX50	ENSG00000008056	"Synapsin I"	P17600	X	47571901-47619857	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 271.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.1;Excitatory neurons: 37.3;Horizontal cells: 28.6;Inhibitory neurons: 34.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 11.2"	"Group enriched"	"Detected in many"	5	"amygdala: 81.4;basal ganglia: 127.5;cerebral cortex: 271.3;hippocampal formation: 118.3;white matter: 150.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.0;HHSteC: 8.1;NTERA-2: 17.4;SCLC-21H: 30.2;SH-SY5Y: 7.9;SuSa: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced					NA	NA		48000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 41: Macrophages - Immune response"			"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	3.9	11.0	81.4	3.5	127.5	2.0	0.9	9.0	271.3	1.2	0.0	3.7	0.6	1.3	1.4	0.7	1.9	2.6	15.3	118.3	30.7	2.2	3.0	2.9	0.4	28.5	2.3	2.9	2.2	0.7	35.7	4.4	12.7	2.3	1.8	44.0	1.2	1.7	1.9	1.3	1.8	1.7	0.0	1.1	1.9	2.6	9.9	0.9	0.5	3.8	0.7	4.1	1.6	150.4	0.0	0.0	5.0	0.7	0.2	1.0	0.0	0.9	0.2	1.4	0.4	0.0	0.0	0.0	1.6	0.1	1.6	9.0	0.5	0.0	0.4	0.6	0.1	0.5	0.0	0.0	8.1	0.0	2.1	1.9	0.0	1.5	0.3	0.0	0.1	0.7	0.6	0.3	0.2	0.2	0.3	0.3	17.4	0.0	0.1	0.1	0.1	0.3	0.0	0.0	30.2	7.9	0.0	0.1	0.1	7.2	2.2	0.0	0.2	0.0	0.9	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	127.5	9.0	271.3	118.3	30.7	28.5	2.3	12.7	0.0	9.9	150.4	0.2	0.0	0.0	5.5	0.0	0.9	0.6	0.6	0.6	27.1	0.2	0.1	3.7	1.5	0.1	0.0	10.4	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.4	4.2	0.8	37.3	0.7	0.0	2.7	1.1	0.1	0.0	1.6	3.3	1.5	0.2	28.6	34.1	0.3	2.0	1.6	3.4	1.0	2.8	5.1	0.0	7.5	4.7	6.4	0.0	10.6	5.1	0.6	0.2	3.4	0.0	1.2	0.0	0.1	0.1	7.3	6.6	0.8	2.1	3.6	2.1	0.0	0.6	0.0	0.1	3.2	0.5	0.3